{"id":30,"date":"2026-08-31T13:02:52","date_gmt":"2026-08-31T11:02:52","guid":{"rendered":"https:\/\/asmed.net\/adozione-e-supporto\/"},"modified":"2026-09-21T12:54:20","modified_gmt":"2026-09-21T10:54:20","slug":"percorso-e-supporto","status":"publish","type":"page","link":"https:\/\/asmed.net\/en\/percorso-e-supporto\/","title":{"rendered":"Route and Support"},"content":{"rendered":"

\nRoute and Support\n<\/p>

\nFrom first contact to daily clinical use.\n<\/h1>

\nA structured pathway, a single point of contact, no changes to the organisation of your practice: from the first assessment to ongoing assistance.\n<\/p><\/div><\/section>

\nWhere do we start\n<\/p>

\nBefore the device, your practice.\n<\/h2>

\nThe course begins with three questions we ask each professional. They are not about technology: It's about your work.\n<\/p><\/div>

\n01\n<\/div>

\nHow many patients interrupt the traditional pathway early?\n<\/h3>

\nWhen the response is partial, some patients leave. The REAC\u00ae protocols are a complementary, non-invasive option, to be added to the path already set without replacing it.\n<\/p><\/div>

\n02\n<\/div>

\nHow often would you like an extra option, without adding a drug?\n<\/h3>

\nREAC\u00ae treatment is drug-free and, according to the technical documentation, no contraindications to the concomitant use of drug therapies are known.\n<\/p><\/div>

\n03\n<\/div>

\nHow important is it for your structure to innovate without complicating procedures?\n<\/h3>

\nStandardized protocols, sessions of a few minutes, start-up training and a single point of contact: Integration does not require organisational changes.\n<\/p><\/div><\/div><\/div><\/section>

\nThe pathway\n<\/p>

\nFive stages, a single point of contact\n<\/h2><\/div>
  1. \n01\n<\/span>

    \nKnowledge\n<\/h3>\nPresentation of REAC\u00ae Technology, devices and reference literature.\n<\/span><\/li>
  2. \n02\n<\/span>

    \nAssessment\n<\/h3>\nAnalysis of protocol integration into clinical practice and practice organisation.\n<\/span><\/li>
  3. \n03\n<\/span>

    \nTraining\n<\/h3>\nTraining in the use of the device and protocols, with dedicated material and documentation.\n<\/span><\/li>
  4. \n04\n<\/span>

    \nIntegration\n<\/h3>\nStart of clinical use with support in the first applications of the protocols.\n<\/span><\/li>
  5. \n05\n<\/span>

    \nAssistance\n<\/h3>\nContinuous technical assistance and scientific support, updates and maintenance.\n<\/span><\/li><\/ol><\/section>

    \nWhat the pathway involves\n<\/h2><\/div>

    \nFor the professional\n<\/h3>
    \n